(SNDX) |
| 0 (0%) 08-29 17:53 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 25.19 |
| Resistance 1: | 21.57 |
| Pivot price: | 19.90 |
| Support 1: | 18.87 |
| Support 2: | 17.20 |
| 52w High: | |
| 52w Low: |
| EPS | -2.510 |
| Book Value | 0.170 |
| PEG Ratio | 0.00 |
| Gross Profit | -0.226 |
| Profit Margin (%) | -87.52 |
| Operating Margin (%) | -54.95 |
| Return on Assets (ttm) | -18.7 |
| Return on Equity (ttm) | -255.9 |
Fri, 28 Aug 2026
864,986 Shares in Syndax Pharmaceuticals, Inc. $SNDX Acquired by Palo Alto Investors LP - MarketBeat
Fri, 28 Aug 2026
Deutsche Bank AG Purchases New Shares in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Fri, 28 Aug 2026
BlackRock Inc. Makes New Investment in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Tue, 25 Aug 2026
Syndax Pharmaceuticals (SNDX), Why Is It Drawing Fresh Attention? - simplywall.st
Tue, 25 Aug 2026
Syndax Pharmaceuticals (SNDX) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Tue, 18 Aug 2026
When Will Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Breakeven? - Moomoo
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |